HQL
Abrdn Life Sciences InvestorsยทNYSE
--
--(--)
--
--(--)
7.92 / 10
Outperform
Capital flow assessment yields 7.92/10, denoting robust fund flow characteristics. Positive liquidity outlook is observed across overall, block, small, medium, large, and extra-large scales, suggesting sustained investor interest.
Fund Flow Rating
Is money flowing into or out of HQL?
- HQL holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.92/10 (Outperform).
